{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T16:46:39Z","timestamp":1792082799950,"version":"4.4.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2024,10,11]],"date-time":"2024-10-11T00:00:00Z","timestamp":1728604800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,10,11]],"date-time":"2024-10-11T00:00:00Z","timestamp":1728604800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Targ Oncol"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1007\/s11523-024-01098-1","type":"journal-article","created":{"date-parts":[[2024,10,11]],"date-time":"2024-10-11T14:01:40Z","timestamp":1728655300000},"page":"867-877","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Pancreatitis in Patients with Cancer Receiving Immune Checkpoint Inhibitors: A Systematic Review and Meta-analysis"],"prefix":"10.1007","volume":"19","author":[{"given":"Mako","family":"Koseki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshito","family":"Nishimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelyn","family":"Elias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Estaris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fnu","family":"Chesta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kensuke","family":"Takaoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuyuki","family":"Horita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1406-2352","authenticated-orcid":false,"given":"Yu","family":"Fujiwara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,11]]},"reference":[{"issue":"1","key":"1098_CR1","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s40425-019-0502-7","volume":"7","author":"H Abu-Sbeih","year":"2019","unstructured":"Abu-Sbeih H, Tang T, Lu Y, Thirumurthi S, Altan M, Jazaeri AA, et al. Clinical characteristics and outcomes of immune checkpoint inhibitor-induced pancreatic injury. J Immunother Cancer. 2019;7(1):31.","journal-title":"J Immunother Cancer"},{"issue":"29","key":"1098_CR2","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000029612","volume":"101","author":"J Malet","year":"2022","unstructured":"Malet J, Melki B, Chouabe S, Desl\u00e9e G. Immune-related pancreatitis due to anti-PD-L1 therapy in a patient with non\u2013small cell lung cancer: a case report. Medicine. 2022;101(29): e29612.","journal-title":"Medicine"},{"key":"1098_CR3","doi-asserted-by":"crossref","unstructured":"Rom\u00e3o R, Mendes AS, Ranchor R, Ramos MJ, Coelho J, Pichel RC, et al. Impact of immune-related adverse events on immune checkpoint inhibitors treated cancer patients' survival: single center experience and literature review. Cancers (Basel). 2023;15(3):888.","DOI":"10.3390\/cancers15030888"},{"issue":"2","key":"1098_CR4","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1056\/NEJMra1703481","volume":"378","author":"MA Postow","year":"2018","unstructured":"Postow MA, Sidlow R, Hellmann MD. Immune-related adverse events associated with immune checkpoint blockade. N Engl J Med. 2018;378(2):158\u201368.","journal-title":"N Engl J Med"},{"key":"1098_CR5","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.ejca.2016.02.025","volume":"60","author":"L Hofmann","year":"2016","unstructured":"Hofmann L, Forschner A, Loquai C, Goldinger SM, Zimmer L, Ugurel S, et al. Cutaneous, gastrointestinal, hepatic, endocrine, and renal side-effects of anti-PD-1 therapy. Eur J Cancer. 2016;60:190\u2013209.","journal-title":"Eur J Cancer"},{"key":"1098_CR6","doi-asserted-by":"publisher","first-page":"1166299","DOI":"10.3389\/fimmu.2023.1166299","volume":"14","author":"Z Zhao","year":"2023","unstructured":"Zhao Z, Zhang W, Pang L, Zeng L, Liu S, Liu J. Pancreatic adverse events of immune checkpoint inhibitors therapy for solid cancer patients: a systematic review and meta-analysis. Front Immunol. 2023;14:1166299.","journal-title":"Front Immunol"},{"issue":"5","key":"1098_CR7","doi-asserted-by":"publisher","first-page":"763","DOI":"10.3390\/healthcare10050763","volume":"10","author":"R Nakano","year":"2022","unstructured":"Nakano R, Shiomi H, Fujiwara A, Yoshihara K, Yoshioka R, Kawata S, et al. Clinical characteristics of ICI-related pancreatitis and cholangitis including radiographic and endoscopic findings. Healthcare. 2022;10(5):763.","journal-title":"Healthcare"},{"issue":"4","key":"1098_CR8","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.pan.2019.04.015","volume":"19","author":"J George","year":"2019","unstructured":"George J, Bajaj D, Sankaramangalam K, Yoo JW, Joshi NS, Gettinger S, et al. Incidence of pancreatitis with the use of immune checkpoint inhibitors (ICI) in advanced cancers: a systematic review and meta-analysis. Pancreatology. 2019;19(4):587\u201394.","journal-title":"Pancreatology"},{"key":"1098_CR9","doi-asserted-by":"crossref","unstructured":"Hori Y, Naitoh I, Naiki-Ito A, Kawai T, Yoshida M, Kato A, et al. Incidence of pancreatic injury and pancreatitis in patients treated with immune checkpoint inhibitors. Clin Transl Gastroenterol. 2024;15(4):e00667.","DOI":"10.14309\/ctg.0000000000000667"},{"issue":"6","key":"1098_CR10","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-002435","volume":"9","author":"JR Brahmer","year":"2021","unstructured":"Brahmer JR, Abu-Sbeih H, Ascierto PA, Brufsky J, Cappelli LC, Cortazar FB, et al. Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune checkpoint inhibitor-related adverse events. J Immunother Cancer. 2021;9(6): e002435.","journal-title":"J Immunother Cancer"},{"issue":"1","key":"1098_CR11","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/S1470-2045(23)00524-7","volume":"25","author":"Y Fujiwara","year":"2024","unstructured":"Fujiwara Y, Horita N, Adib E, Zhou S, Nassar AH, Asad ZUA, et al. Treatment-related adverse events, including fatal toxicities, in patients with solid tumours receiving neoadjuvant and adjuvant immune checkpoint blockade: a systematic review and meta-analysis of randomised controlled trials. Lancet Oncol. 2024;25(1):62\u201375.","journal-title":"Lancet Oncol"},{"issue":"12","key":"1098_CR12","doi-asserted-by":"publisher","first-page":"2837","DOI":"10.1007\/s00262-022-03203-7","volume":"71","author":"Y Fujiwara","year":"2022","unstructured":"Fujiwara Y, Horita N, Harrington M, Namkoong H, Miyashita H, Galsky MD. Incidence of hepatotoxicity associated with addition of immune checkpoint blockade to systemic solid tumor therapy: a meta-analysis of phase 3 randomized controlled trials. Cancer Immunol Immunother. 2022;71(12):2837\u201348.","journal-title":"Cancer Immunol Immunother"},{"key":"1098_CR13","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.ejca.2021.03.012","volume":"150","author":"Y Fujiwara","year":"2021","unstructured":"Fujiwara Y, Horita N, Namkoong H, Galsky MD. The effect of adding immune checkpoint inhibitors on the risk of pneumonitis for solid tumours: a meta-analysis of phase III randomised controlled trials. Eur J Cancer. 2021;150:168\u201378.","journal-title":"Eur J Cancer"},{"key":"1098_CR14","doi-asserted-by":"crossref","unstructured":"Oliveira C, Mainoli B, Duarte GS, Machado T, Tinoco RG, Esperan\u00e7a-Martins M, et al. Immune-related serious adverse events with immune checkpoint inhibitors: Systematic review and network meta-analysis. Eur J Clin Pharmacol. 2024;80(5):677\u2013684.","DOI":"10.1007\/s00228-024-03647-z"},{"key":"1098_CR15","doi-asserted-by":"crossref","unstructured":"Zhang T, Wang Y, Shi C, Liu X, Lv S, Wang X, et al. Pancreatic injury following immune checkpoint inhibitors: a systematic review and meta-analysis. Front Pharmacol. 2022;13:955701.","DOI":"10.3389\/fphar.2022.955701"},{"issue":"7","key":"1098_CR16","doi-asserted-by":"publisher","first-page":"e116","DOI":"10.2337\/dc18-2518","volume":"42","author":"S Yoneda","year":"2019","unstructured":"Yoneda S, Imagawa A, Hosokawa Y, Baden MY, Kimura T, Uno S, et al. T-lymphocyte infiltration to islets in the pancreas of a patient who developed type 1 diabetes after administration of immune checkpoint inhibitors. Diabetes Care. 2019;42(7):e116\u20138.","journal-title":"Diabetes Care"},{"issue":"7","key":"1098_CR17","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1097\/CJI.0000000000000472","volume":"46","author":"S Kramer","year":"2023","unstructured":"Kramer S, van Hee K, Blokzijl H, van der Heide F, Visschedijk MC. Immune checkpoint inhibitor-related pancreatitis: a case series, review of the literature and an expert opinion. J Immunother. 2023;46(7):271\u20135.","journal-title":"J Immunother"}],"container-title":["Targeted Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11523-024-01098-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11523-024-01098-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11523-024-01098-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,13]],"date-time":"2024-11-13T05:07:08Z","timestamp":1731474428000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11523-024-01098-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,11]]},"references-count":17,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["1098"],"URL":"https:\/\/doi.org\/10.1007\/s11523-024-01098-1","relation":{},"ISSN":["1776-2596","1776-260X"],"issn-type":[{"value":"1776-2596","type":"print"},{"value":"1776-260X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,11]]},"assertion":[{"value":"30 August 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No external funding was used in the preparation of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Mako Koseki, Yoshito Nishimura, Evelyn Elias, Jonathan Estaris, Fnu Chesta, Kensuke Takaoka, Theresa Shao, Nobuyuki Horita, and Yu Fujiwara declare that they have no conflicts of interest that might be relevant to the contents of this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"Not required.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"All data generated or analyzed during this study are included in this published article (and its supplementary information files).","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of Data and Material:"}},{"value":"Data are available in a public, open-access repository. All data relevant to the study are included in the article or uploaded as supplementary information.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data Sharing Statement"}},{"value":"Not applicable.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"M.K.: Conceptualization, formal analysis, investigation, data curation, resources, statistical analysis, writing\u2014original draft, and visualization. Y.N.: Investigation, data curation, and writing\u2014review and editing. E.E.: Investigation, data curation, and writing\u2014review and editing. J.E.: Investigation, data curation, and writing\u2014review and editing. F.C.: Investigation data curation, and writing \u2013 review and editing. K.T.: Investigation, data curation, and writing\u2014review and editing. T.S: Investigation, data curation, writing\u2014review and editing, and supervision. N.H: Investigation, statistical analysis, writing\u2014review and editing, and supervision. Y.F.: Conceptualization, data curation, formal analysis, investigation, statistical analysis, and writing\u2014review and editing, visualization, and supervision. Guarantor of the article: Y.F.","order":10,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors' Contributions"}}]}}